Global Tobacco Control Policy Debate: Medical Experts Call for Science-Based Approach, Promoting Harm Reduction Over Total Bans

Sep.09
Health professionals worldwide are urging a shift from abstinence-only tobacco policies toward evidence-based harm reduction. Despite bans, smoking remains prevalent in countries like India, while prohibition fuels black markets in Europe and misinformation among doctors in the U.S. Many argue that regulated alternatives could save lives where cessation fails.

Key Points:

 

·Smoking causes millions of preventable deaths yearly, yet harm reduction is often ignored.

·India’s vaping ban failed to reduce smoking; instead, illicit markets grew.

·Doctors in India, the U.S., and Europe are advocating for regulated smoke-free alternatives.

·Many U.S. physicians are misinformed—most don’t know nicotine isn’t the primary cause of cancer.

·Prohibition enables youth access via black markets and social media, as seen in the Netherlands.

·Experts emphasize: quitting is best, but safer alternatives should be available for those who can’t quit.

 


 

2Firsts, September 9th - according to vaping post reported in September 8th, for over a century, smoking has been a major cause of preventable death globally. It kills more than a million people each year in India, nearly half a million in the U.S., and in Europe, youth nicotine use is increasingly linked to black markets and online loopholes. Despite the severe toll, many governments remain skeptical of harm reduction or ignore it entirely. Now, more health professionals are urging policies grounded in science and compassion.

 

India’s experience highlights the consequences. Despite a 2019 ban on e-cigarettes, smoking rates remain high, with over 253 million Indians using tobacco—often in dangerous forms like bidis and gutkha. Instead of reducing demand, the ban fueled a black market for unregulated products.

 

Some doctors are challenging this approach. Vaibhav Sahni and Abhishek Shankar from AIIMS argued that regulated e-cigarettes could help smokers transition away from combustible tobacco and should be part of a harm reduction strategy. Their institution quickly distanced itself from the view, but the debate reflects a growing shift toward evidence-based policy.

 

Other countries offer alternative models. The UK, for example, promotes regulated smoke-free alternatives for adults while protecting youth. Such frameworks acknowledge that while quitting is best, safer options should exist for those who can’t or won’t stop.

 

In the U.S., a survey of healthcare providers found that 93% believe the FDA should share information about less harmful smoke-free products. Yet, most doctors remain unaware of authorized alternatives, and many mistakenly believe nicotine causes cancer. In fact, most harm comes from combustion, not nicotine. This misinformation reinforces an unrealistic “quit or die” approach.

 

In Europe, prohibition has also led to unintended outcomes. Following a ban on flavored vapes in the Netherlands, illegal products with high nicotine levels flooded the market. Doctors report rising youth vaping, fueled by social media and underground sales.

 

Across regions, prohibition often creates black markets, leaves doctors misinformed, and limits choices for smokers. Many health experts are now calling for pragmatic harm reduction: policies that recognize different levels of risk, educate clinicians, and provide adults with safer alternatives.

 

The best option will always be to quit entirely. But for those who can’t, having no safer alternative isn’t protection—it’s a failure of public health. Governments should empower doctors with accurate information, support responsible regulation, and move beyond the false choice between quitting and continuing to smoke.
 

Altria and KT&G sign a memorandum of understanding to acquire nicotine pouch company ASF and expand into the global market
Altria and KT&G sign a memorandum of understanding to acquire nicotine pouch company ASF and expand into the global market
In 2025, Altria Group, Inc. of the United States announced the signing of a Memorandum of Understanding on Global Cooperation with South Korea's KT&G Company, aiming to find growth opportunities in the fields of modern oral nicotine products and non-nicotine products and improve the efficiency of traditional tobacco business.
Sep.24 by 2FIRSTS.ai
IHit-HyperV Ceramic Atomization Technology Achieves Commercial Maturity, Redefining the New Standard for Visible E-liquid Pod Systems
IHit-HyperV Ceramic Atomization Technology Achieves Commercial Maturity, Redefining the New Standard for Visible E-liquid Pod Systems
At the 2025 CHAMPS Trade Show, iHit Tech (SMISS Group) announced the commercial maturity of its IHit-HyperV ceramic atomization technology. The breakthrough boosts efficiency and flavor performance, setting a new benchmark for visible e-liquid pod systems.
Sep.15
NZ school principal says student vaping has eased markedly from the post-pandemic peak
NZ school principal says student vaping has eased markedly from the post-pandemic peak
Daryl Gibbs, principal of Cambridge Middle School and president of the New Zealand Association of Intermediate and Middle Schools, says student vaping has fallen noticeably over the past two years after a sharp post-COVID surge. At the peak, schools deployed measures such as vape monitors and coordinated responses among principals; today his school is dealing with only a handful of repeat cases. Gibbs backs tighter access rules and stresses families’ primary role in prevention, remarks he made a
Sep.11 by 2FIRSTS.ai
UK plans law to license vape retailers; unlicensed sales could face heavy fines
UK plans law to license vape retailers; unlicensed sales could face heavy fines
The UK plans a national licensing regime for vape and tobacco sales, making unlicensed retail illegal, and will consult experts on flavours, nicotine strength, packaging and design.
Oct.09 by 2FIRSTS.ai
Oregon Supreme Court to Hear Case Challenging Restrictions on E-Cigarette Descriptions
Oregon Supreme Court to Hear Case Challenging Restrictions on E-Cigarette Descriptions
The Oregon Supreme Court prepares to review a case challenging restrictions on e-cigarette product descriptions, impacting small businesses and consumers.
Sep.22 by 2FIRSTS.ai
Reuters: FDA relaxes requirements for nicotine pouch pilot program, cancels special research on some products
Reuters: FDA relaxes requirements for nicotine pouch pilot program, cancels special research on some products
US FDA meeting minutes: Under Trump, a new pilot eases nicotine pouch rules—cuts product-specific research (uses generic data), shortens reviews, boosts communication. It’s the FDA’s first clear softer stance on smoking alternatives. The pilot may benefit Philip Morris (Zyn), Altria (On!), BAT (Velo) but sparks debate: FDA says pouches are low-risk (no youth surge), while ex-officials/academics cite missing research (hurts health checks, risks hidden youth use). Firms note costly research remain
Sep.19 by 2FIRSTS.ai